Joerg Schwarz, M.S., is the Senior Director of Healthcare Interoperability at Infor. He believes providers will harness the power of generative AI in 2024.
We asked our readers and some members of our editorial advisory board to make predictions for 2024. Here's what Joerg Schwarz, M.S., had to say:
"Healthcare executives are cautious about using generative artificial intelligence (AI) for clinical content, and we can expect this apprehension to extend well into 2024, primarily because of the overabundance of unstructured data. Healthcare chief information officers and chief technology officers will begin implementing a data analytics platform strategy combining data from different sources (Internet of Things, electronic health records, enterprise resource planning) in 2024, with hopes of using this platform to feed the many AI algorithms that promise improved operational and clinical outcomes.
Although healthcare providers recognize the potential of generative AI, 2024 will be the year when organizations come together and work to train algorithms for reliable results, in parallel with good governance models.”
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Medicaid Expansion Linked To Timelier Lung Cancer Surgery and Access to High-Volume Hospitals
April 17th 2025New research shows that Medicaid expansion was linked to a 2.1% increase in timely lung cancer surgeries and a 2.8% rise in procedures at high-volume hospitals, highlighting how policy changes can impact cancer care access.
Read More